Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Gynecol Oncol. 2021 Nov 8;164(1):12–17. doi: 10.1016/j.ygyno.2021.10.087

Table 1:

Study population

Characteristic N (%)
Race
White 48 (81%)
Asian 5 (9%)
Black or African American 2 (3%)
Unknown 4 (7%)
Histology
High-grade serous 45 (76%)
Low-grade serous 14 (24%)
Debulking surgery
Optimal 53 (90%)
Suboptimal 5 (8%)
Unknown 1 (2%)
Prior lines of chemotherapy
1 line 11 (19%)
2 lines 32 (54%)
3 lines 16 (27%)
Prior hormonal therapy
No 46 (78%)
Yes 13 (22%)
Prior radiation therapy
No 58 (98%)
Yes 1 (2%)